Decline in eGFR in HCV-infected patients while on treatment with sofosbuvir/ledipasvir or PrOD regimens is not dependent on baseline eGFR

Authors :: Jean Marie Arduino
Adeel A. Butt
Amy Puenpatom
Abdul-Badi Abou-Samra
Y. Ren
Mohamad Alkadi
Ritesh N. Kumar
Source :: Journal of Hepatology. 66:S724
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
Ledipasvir
medicine.medical_specialty
chemistry.chemical_compound
Hepatology
Sofosbuvir
chemistry
business.industry
Internal medicine
medicine
business
Virology
medicine.drug

Full Text Access

Tools